Investing in Novel Treatments for Better Health
The McQuade Center for Strategic Research and Development, LLC (MSRD) was established in 2019 by the Otsuka US Pharmaceutical Business. MSRD is named for Dr. Robert McQuade, Chief Strategic Officer for Otsuka in the US and President of MSRD.
MSRD helps advance studies in:
CENTRAL NERVOUS SYSTEM
RENAL
AREAS OF UNDERSERVED
MEDICAL NEEDS
"Otsuka is dedicated to investing in innovative and creative products that contribute to the lives of people everywhere. MSRD was created as an extension of this commitment to support and identify early stage opportunities that can change the landscape of how we treat mental illness and renal disorders in the future."
Dr. Robert McQuade
Chief Strategic Officer, Otsuka US
President of MSRD
Our Mission
The purpose of MSRD is to search for, identify and fund innovative early-stage research/development programs that have the potential to build the future portfolio of Otsuka products.
Our Approach
DISCOVERY
Search for early stage, creative assets and programs
DIALOGUE
Establish open communication and agile collaboration
DELIVERY
Invest in novel treatments that address unmet medical need
Leading the Charge
In this Fireside Chat, Dr. William Carson, Chairman of the Board, Otsuka Pharmaceutical Development & Commercialization and Kabir Nath, President & CEO, Otsuka North America Pharmaceuticals chat with Logan Plaster, Media Director, StartUp Health on "The Mental Health & Happiness Moonshot: How A Pharma Company is Leading the Charge" at the 2019 StartUp Health Festival in San Francisco, California. MSRD builds on Otsuka’s innovative approach by investing in treatment options that may offer better health outcomes for those living with mental illness.
Featured News
The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic Medicines
PRINCETON, NJ – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. (Mindset) (CSE: MSET…
The McQuade Center for Strategic Research and Development Launches the Otsuka Digital Pioneer Initiative
PRINCETON, NJ – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces today the launch of Otsuka’s Digital…
The McQuade Center for Strategic Research and Development Enters Agreement with Sentinel Oncology to Develop Breakthrough Treatment for Fragile X Syndrome
PRINCETON, NJ – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces today that it has entered an…
McQuade Center for Strategic Research and Development Enters Collaboration with Aché to Develop Potential Treatment for General Anxiety Disorder and Post-Traumatic Stress Disorder
PRINCETON, NJ – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces today that it has entered an…
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
PRINCETON, N.J. – (February 9, 2021) – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces it has…
MSRD Enters Collaboration Agreement with Rugen Holdings (Cayman) Limited to Develop Novel Treatment for Patients with Diverse Psychiatric Disorders
Activities will support the clinical development of Rugen’s potential first-in-class, orally administered drug candidate with initial clinical focus on treatment-resistant depression. PRINCETON,…Our Team
Dr. Robert McQuade
Chief Strategic Officer, Otsuka US
President of MSRD
Dr. Xilu Jiao
Director
Strategic Research & Development
Nicole Sroczynski
Associate Director
Strategic Research & Development
Dr. Nathan Styles
Executive Director
Strategic Research & Development
Dr. Alex Goddard
Director
Strategic Research & Development
Dr. Carolyn Tyler
Senior Director
Strategic Research and Development